Terug
Dagbereik
€ 21,90
€ 23,52
52-Weeksbereik
€ 1,92
€ 31,18
Volume
457.975
50D / 200D Gem.
€ 25,15
/
€ 16,46
Vorige Slotkoers
€ 22,25
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,7 | 0,4 |
| P/B | 7,8 | 2,9 |
| ROE % | -84,7 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Hold
€ 35,00
+57.4%
Low: € 17,00
High: € 50,00
Forward WPA
-€ 3,73
Omzet Sch.
11 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,43
€ 0,43 – € 0,43
|
430 M | 1 |
| FY2028 |
-€ 1,42
-€ 1,42 – -€ 1,42
|
210 M | 1 |
| FY2027 |
-€ 3,48
-€ 3,99 – -€ 3,25
|
51 M | 4 |
Belangrijkste Punten
Debt/Equity of 0,47 — conservative balance sheet
Negative free cash flow of -117,72M
PEG of 0,09 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-84,70%
ROIC-63,52%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,47
Current Ratio6,72
Interest Coverage0,00
Waardering
P/E Ratio
-6,68
P/B Ratio7,83
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -176,21M |
| ROE | -84,70% | ROA | -52,51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -117,72M |
| ROIC | -63,52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,47 | Current Ratio | 6,72 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,68 | P/B Ratio | 7,83 |
| P/S Ratio | N/A | PEG Ratio | 0,09 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,18B | Enterprise Value | 1,08B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -176,21M | -260,49M | -333,82M | -266,99M | -133,10M |
| EPS (Diluted) | -3,35 | -4,97 | -6,39 | -5,16 | -2,91 |
| Gross Profit | -26,71M | -25,95M | -11,00M | -8,71M | -4,21M |
| Operating Income | -186,85M | -277,32M | -341,38M | -267,05M | -136,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 335,58M | 479,37M | 666,63M | 904,22M | 1,07B |
| Total Liabilities | 185,29M | 213,59M | 230,46M | 240,90M | 206,60M |
| Shareholders' Equity | 150,29M | 265,78M | 436,17M | 663,32M | 860,75M |
| Total Debt | 70,35M | 181,63M | 187,73M | 179,94M | 77,40M |
| Cash & Equivalents | 168,07M | 285,51M | 190,43M | 731,51M | 944,40M |
| Current Assets | 171,94M | 289,31M | 486,01M | 734,81M | 972,01M |
| Current Liabilities | 25,57M | 41,73M | 52,50M | 64,68M | 31,42M |